Small Molecule Inhibition of SIRT Activity: A Novel Therapeutic Approach for Refractory Multiple Myeloma
Steffan T. Nawrocki(University of Arizona), Jennifer S. Carew(University of Arizona), Kevin R. Kelly(Keck Hospital of USC), Valeria Visconte(Cleveland Clinic), Claudia M. Espitia(The University of Texas System), Yingchun Han(Cleveland Clinic)
Cited by 0
Related Papers
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
|Cancer Letters|2008|426
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
|Clinical Cancer Research|2015|355